alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.6.3 


 


	CONFIDENTIAL	 




 


SECOND AMENDMENT TO


COMMERCIALIZATION AGREEMENT


 


THIS Second Amendment to the
January 9, 2017 Commercialization Agreement (“Second Amendment”), effective as of the date this Second Amendment is signed
by both parties (the “Effective Date”), is made by and between Sera Prognostics, Inc. (“Sera”) and Laboratory
Corporation of America Holdings (“Labcorp”). Sera and Labcorp may be referred to herein each as a “Party” or collectively
as “Parties.”


 


RECITALS


 


A.           Sera
and Labcorp entered into a Commercialization Agreement having an effective date of January 9, 2017, as amended June 25, 2018 (the “Agreement”);
and,


 


B.            The
Parties now wish to amend the Agreement in accordance with the terms of this Second Amendment.


 


TERMS


 


NOW, THEREFORE, for good and
valuable consideration, the receipt of which is hereby acknowledged, and the mutual covenants set forth herein, the Parties agree as follows:


 


1.            Section
10.1 of the Agreement is hereby amended and restated as follows:


 


10.1       Term.
This Agreement will commence on the Effective Date and, unless terminated pursuant to the terms hereof, will automatically renew on each
anniversary of the Effective Date.


 


2.        All
capitalized terms used in this Second Amendment and not otherwise defined herein shall have the meanings assigned them in the Agreement.
Except as expressly stated in this Second Amendment, the Agreement remains unchanged and in full force and effect.


 


IN WITNESS WHEREOF, the Parties
hereto have executed this Second Amendment through their authorized representatives signing below.


 


	LABORATORY CORPORATION OF AMERICA HOLDINGS

                                                                                
	 	SERA PROGNOSTICS, INC.
	 	 	 	 	 
	By:	/s/ Michael F. Minahan	 	By:	/s/ Douglas Fisher, MD
	 	 	 	 	 
	Name:	Michael F. Minahan	 	Name:	Douglas Fisher, MD
	 	 	 	 	 
	Title:	SVP & General Manager	 	Title:	Chief Business Officer
	 	 	 	 	 
	Date:	1/26/2021	 	Date:	1/25/2021
May 12, 2016

JUDGMENT

The Fourteenth Court of Appeals

FELIX SANCHEZ-SUAREZ, Appellant

NO. 14-15-00720-CR V.

THE STATE OF TEXAS, Appellee

________________________________

This cause was heard on the transcript of the record of the court below. 

Having considered the record, this Court holds that there was no error in the 

judgment. The Court orders the judgment AFFIRMED.

We further order appellant pay all costs expended in the appeal.

We further order this decision certified below for observance.
<PAGE>

                                                                   Exhibit 10.16

                                    AMENDMENT

                                February 15, 2006

This Amendment dated February 15, 2006 (the "Amendment") hereby amends the
Agreement No. 530133-7202 by and between GTECH Corporation and TransAct
Technologies Incorporated (the "Agreement").

By signing this Amendment, the parties agree to amend the Agreement as follows:

     1.   Section 2.2 of the Agreement is hereby amended to replace "normal
          lead-time of sixty (60) calendar days" with "normal lead time of
          ninety (90) calendar days".

     2.   Section 21.1 of the Agreement is hereby amended to replace "and shall
          continue for five (5) years" with "and shall continue for ten (10)
          years".

     3.   Attachment 2 of the Agreement is hereby amended to replace "Unit Price
          for any quantity is $[*]" with "Unit Price for any quantity is $[*],
          such price effective with orders shipped by VENDOR starting on
          December 4, 2006".

Except as set forth in this Amendment, the Agreement is and shall remain in full
force and effect in accordance with its terms.

TransAct Technologies Incorporated      GTECH Corporation


By: /s/ Bart C. Shuldman                By: /s/ William Middlebrook
    ---------------------------------       ------------------------------------
    Bart C. Shuldman                        William Middlebrook
    Chairman, president & CEO               VP Technology Operations

*    Confidential treatment requested
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr.,

Chief Justice

Stephen J. Markman

Brian K. Zahra

Bridget M. McCormack

David F. Viviano

Richard H. Bernstein

Joan L. Larsen

, Justices

I, Larry S. Royster, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

November 4, 2015 

# Order

Novem ber 4 , 2015

150364 ( 1 11 )

HELEN YONO

, Plaintiff

- Appell ee

,

v

DEPARTMENT OF TRANSPORTATION,

Defendant

- Appellant

. SC: 150364

COA: 308968

Ct of Claims: 11

- 000117

- MD

________________________________________/

On order of the Chief Justice, the motion of the Michigan Association for Justice

for leave to file a brief amicus curiae is GRANTED. The amicus brief submitted on

Octo ber 28 , 2015, is accepted for filing.
Exhibit
10.1


 


RESOLUTIONS
OF THE BOARD OF DIRECTORS OF FOMO CORP.


 





Pursuant
to the provisions of California Corporation law, as amended, and the Certificate of Incorporation and By-Laws of FOMO CORP., a California
corporation (the “Company”), the undersigned approves entering into exclusive negotiations and a no shop window for a period
of no more than 90 days with Homeland Resources Ltd. (HMLA) for the purpose of selling its ownership in KANAB CORP. to HMLA in an equity-linked
transaction. The Board meeting was convened on June 22, 2021 at 6:00am CT.


 


WHEREAS,
to realize maximum value from its holdings in its Internet business and allow it to obtain its own growth capital, the Board of Directors
approves entering into exclusive negotiations and a no shop window for a period of no more than 90 days with Homeland Resources Ltd.
(HMLA) for the purpose of selling its ownership in KANAB CORP. to HMLA in an equity-linked transaction.


 


WHEREAS,
the Board of Directors believes it is in the best interests of the Company to approve entering into exclusive negotiations and a no shop
window for a period of no more than 90 days with Homeland Resources Ltd. (HMLA) for the purpose of selling its ownership in KANAB CORP.
to HMLA in an equity-linked transaction.


 


NOW
THEREFORE BE IT RESOLVED THAT:


 


RESOLVED,
the Board of Directors approves entering into exclusive negotiations and a no shop window for a period of no more than 90 days with Homeland
Resources Ltd. (HMLA) for the purpose of selling its ownership in KANAB CORP. to HMLA in an equity-linked transaction.


 


RESOLVED,
that any of the Executive Officers of the Company are hereby authorized and directed for and on behalf of the Company to do and perform
all acts and things and execute and deliver all documents and take all such other steps as may be necessary or desirable to give full
effect to the consent resolutions set forth above.


 








		 
	Vikram
  Grover, CEO & Director
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF SERVICE EXPERTS, INC. FOR THE NINE MONTHS ENDED
SEPTEMBER 30, 1996 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<RESTATED>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                          14,139
<SECURITIES>                                         0
<RECEIVABLES>                                   13,259
<ALLOWANCES>                                       508
<INVENTORY>                                      3,594
<CURRENT-ASSETS>                                34,217
<PP&E>                                          18,423
<DEPRECIATION>                                   8,965
<TOTAL-ASSETS>                                  46,005
<CURRENT-LIABILITIES>                           16,104
<BONDS>                                          6,246
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            96
<OTHER-SE>                                      23,111
<TOTAL-LIABILITY-AND-EQUITY>                    46,005
<SALES>                                         55,543
<TOTAL-REVENUES>                                55,543
<CGS>                                           39,564
<TOTAL-COSTS>                                   39,564
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 583
<INCOME-PRETAX>                                  2,829
<INCOME-TAX>                                       263
<INCOME-CONTINUING>                              2,566
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,566
<EPS-PRIMARY>                                     0.69
<EPS-DILUTED>                                     0.69
        

</TABLE>
#### In the Matter of Margaret Schieble, Appellant-Respondent, v David Schieble, Respondent-Appellant.

Order unanimously modified on the law and in the exercise of discretion and as modified affirmed without costs, in accordance with the following memorandum: Family Court abused its discretion by limiting its upward modification of child support from $60 to $75 per week. The court placed undue emphasis upon the debts that respondent accumulated following his remarriage in 1982 and failed to recognize that respondent’s obligation to repay the subpay loan from his employer ($100 per week) was satisfied by the time of the court’s award. The record indicates that petitioner earns about $10,000 annually and respondent earns in excess of $30,000. Respondent’s wife also earns nearly $10,000 per year. We find that an award of $100 per week for child support is warranted by the record. (Appeals from order of Erie County Family Court, Sedita, J.—modification of child support.) Present—Dillon, P. J., Denman, Green, Balio and Davis, JJ.
I 

114TH CONGRESS 

1ST SESSION H. R. 220 

To amend title 38, United States Code, to increase the maximum age for 

children eligible for medical care under the CHAMPVA program. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 8, 2015 

Mr. FORTENBERRY introduced the following bill; which was referred to the 

Committee on Veterans’ Affairs 

A BILL 

To amend title 38, United States Code, to increase the 

maximum age for children eligible for medical care under 

the CHAMPVA program. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Veterans Dependents’ 

5 Parity Act’’. 


emcdonald on DSK67QTVN1PROD with BILLS
2 

•HR 220 IH

1 SEC. 2. INCREASE OF MAXIMUM AGE FOR CHILDREN ELIGI2 BLE FOR MEDICAL CARE UNDER CHAMPVA 

3 PROGRAM. 

4 (a) INCREASE.—Subsection (c) of section 1781 of 

5 title 38, United States Code, is amended to read as fol6 lows: 

7 ‘‘(c)(1) Notwithstanding clauses (i) and (iii) of sec8 tion 101(4)(A) of this title, for purposes of this section, 

9 a child who is eligible for benefits under subsection (a) 

10 shall be eligible for benefits under this section until the 

11 child’s 26th birthday, regardless of the marital status of 

12 the child or whether the child is pursuing a full-time 

13 course of instruction at an educational institution. 

14 ‘‘(2) This subsection shall not be construed to limit 

15 eligibility for coverage of a child described in section 

16 101(4)(A)(ii) of this title.’’. 

17 (b) EFFECTIVE DATE.—Such subsection, as so 

18 amended, shall apply with respect to medical care provided 

19 on or after the date of the enactment of this Act. 

Æ 


emcdonald on DSK67QTVN1PROD with BILLS
Exhibit 32.1



CERTIFICATION PURSUANT TO
SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002



I, Robert B. Ladd, President
and Chief Executive Officer of MGT Capital Investments, Inc. (the “Company”), certify, pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my knowledge:



| | (1) | the Quarterly Report on Form 10-Q of the Company for the period ended March 31, 2013 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------





|May 20, 2013 | By: | /s/ ROBERT B. LADD                   
|------------ | --- | -------------------------------------
|             |     | Robert B. Ladd                       
|             |     | President and Chief Executive Officer
EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of TransAct Technologies Incorporated (the Company)
on Form 10-K for the period ending December 31, 2007, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Bart C. Shuldman, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------

Date: March 14, 2008



|                                        
|----------------------------------------
|/s/    BART C. SHULDMAN                 
|Bart C. Shuldman Chief Executive Officer
[Federal Register Volume 86, Number 180 (Tuesday, September 21, 2021)]
[Notices]
[Page 52479]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20370]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Tropical Medicine Research Centers 
(U01 Clinical Trial Not Allowed).
    Date: October 18-19, 2021.
    Time: 10:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G62A, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Eleazar Cohen, Ph.D., Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, 
National Institute of Allergy and Infectious Diseases, National 
Institutes of Health, 5601 Fishers Lane, Room 3G62A, Rockville, MD 
20852, (240) 669-5081, <a href="/cdn-cgi/l/email-protection#2b4e4844434e456b45424a424f05454243054c445d"><span class="__cf_email__" data-cfemail="3f5a5c50575a517f51565e565b1151565711585049">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: September 15, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-20370 Filed 9-20-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
##### 



EXHIBIT 32.2 CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the accompanying Quarterly Report of Prescient Applied Intelligence, Inc. f/k/a
The viaLink Company (the Company) on Form 10-KSB for the period ending December 31, 2004 as filed
with the Securities and Exchange Commission on the date hereof (the Report), I, Stan Szczygiel,
Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350,
as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:  1.
    The Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and2.
    The information contained in the Report fairly presents, in all material respects,
the financial condition and result of operations of the Company. /s/ Stan SzczygielStan SzczygielVice President and Chief Financial OfficerMarch 31, 2005
[Federal Register Volume 86, Number 176 (Wednesday, September 15, 2021)]
[Notices]
[Page 51432]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19877]


-----------------------------------------------------------------------

SMALL BUSINESS ADMINISTRATION

[Disaster Declaration #17159 and #17160; New York Disaster Number NY-
00204]


Administrative Declaration of a Disaster for the State of New 
York

AGENCY: U.S. Small Business Administration.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This is a notice of an Administrative declaration of a 
disaster for the State of New York dated 09/09/2021.
    Incident: Severe Storms and Flooding.
    Incident Period: 07/14/2021.

DATES: Issued on 09/09/2021.
    Physical Loan Application Deadline Date: 11/08/2021.
    Economic Injury (EIDL) Loan Application Deadline Date: 06/09/2022.

ADDRESSES: Submit completed loan applications to: U.S. Small Business 
Administration, Processing and Disbursement Center, 14925 Kingsport 
Road, Fort Worth, TX 76155.

FOR FURTHER INFORMATION CONTACT: A. Escobar, Office of Disaster 
Assistance, U.S. Small Business Administration, 409 3rd Street SW, 
Suite 6050, Washington, DC 20416, (202) 205-6734.

SUPPLEMENTARY INFORMATION: Notice is hereby given that as a result of 
the Administrator's disaster declaration, applications for disaster 
loans may be filed at the address listed above or other locally 
announced locations.
    The following areas have been determined to be adversely affected 
by the disaster:

Primary Counties: Rensselaer.
Contiguous Counties:
    New York: Albany, Columbia, Greene, Saratoga, Washington.
    Vermont: Bennington.
    Massachusetts: Berkshire.

    The Interest Rates are:

------------------------------------------------------------------------
                                                                Percent
------------------------------------------------------------------------
For Physical Damage:
  Homeowners with Credit Available Elsewhere.................      3.250
  Homeowners without Credit Available Elsewhere..............      1.625
  Businesses with Credit Available Elsewhere.................      5.760
  Businesses without Credit Available Elsewhere..............      2.880
  Non-Profit Organizations with Credit Available Elsewhere...      2.000
  Non-Profit Organizations without Credit Available Elsewhere      2.000
For Economic Injury:
  Businesses & Small Agricultural Cooperatives without Credit      2.880
   Available Elsewhere.......................................
  Non-Profit Organizations without Credit Available Elsewhere      2.000
------------------------------------------------------------------------

    The number assigned to this disaster for physical damage is 17159 6 
and for economic injury is 17160 0.
    The States which received an EIDL Declaration # are New York, 
Massachusetts, Vermont.

(Catalog of Federal Domestic Assistance Number 59008)

Isabella Guzman,
Administrator.
[FR Doc. 2021-19877 Filed 9-14-21; 8:45 am]
BILLING CODE 8026-03-P
#### The People of the State of New York, Respondent, v Miguel Baez, Appellant.

Appeal by the defendant from a judgment of the Supreme Court, Kings County (Moskowitz, J.), rendered December 18, 1985, convicting him of rape in the first degree, upon his plea of guilty, and imposing sentence.

Ordered that the judgment is affirmed.

We have reviewed the record and agree with the defendant’s assigned counsel that there are no meritorious issues which could be raised on appeal. Counsel’s application for leave to withdraw as counsel is granted *(see, Anders v California,*386 US 738; *People v Paige,*54 AD2d 631; *cf., People v Gonzalez,*47 NY2d 606). Thompson, J. P., Niehoff, Eiber, Sullivan and Harwood, JJ., concur.